Net profit of Thyrocare Technologies rose 41.11% to Rs 17.78 crore in the quarter ended March 2024 as against Rs 12.60 crore during the previous quarter ended March 2023. Sales rose 13.52% to Rs 154.25 crore in the quarter ended March 2024 as against Rs 135.88 crore during the previous quarter ended March 2023.
For the full year,net profit rose 9.72% to Rs 70.76 crore in the year ended March 2024 as against Rs 64.49 crore during the previous year ended March 2023. Sales rose 8.58% to Rs 571.88 crore in the year ended March 2024 as against Rs 526.67 crore during the previous year ended March 2023.
| Particulars | Quarter Ended | Year Ended |
| | Mar. 2024 | Mar. 2023 | % Var. | Mar. 2024 | Mar. 2023 | % Var. |
| Sales | 154.25 | 135.88 | 14 | 571.88 | 526.67 | 9 |
| OPM % | 21.78 | 18.17 | - | 24.03 | 22.79 | - |
| PBDT | 35.96 | 28.04 | 28 | 142.99 | 127.30 | 12 |
| PBT | 22.90 | 17.24 | 33 | 95.98 | 88.59 | 8 |
| NP | 17.78 | 12.60 | 41 | 70.76 | 64.49 | 10 |